BioSpace News Archive

Job Trends

A London AI Hub, a Facility Bigger than the Louvre, Are Among the Newest Footprint Expansions in the Life Sciences Industry

GlaxoSmithKline has opened a new $13 million research hub in London focused on artificial intelligence.

September 3, 2020
·
2 min read
·
Alex Keown
Pharm Country

Lessons From Bergamo: Halting the Complement Cascade May Stop COVID-19 in Its Tracks

Treatments for COVID-19 may be focusing on at the wrong elements of the disease, according to physicians analyzing results from Bergamo, Italy, the epicenter of the pandemic in Europe.

September 3, 2020
·
4 min read
·
Gail Dutton
Policy

FDA Action Alert: Possible COVID-19 Action and Mallinckrodt’s Terlipressin

It’s entirely possible that what we will be seeing most from the U.S. Food and Drug Administration for the month of September is related to treatments and vaccines for COVID-19.

September 3, 2020
·
3 min read
·
Mark Terry
Drug Development

Biopharma Update on the Novel Coronavirus: September 4

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 4, 2020.

September 3, 2020
·
3 min read
·
BioSpace Editorial Staff
Deals

Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion

Funding to advance “home hospital” initiatives with health systems and “beyond the pill” digital therapeutics partnerships with pharmaceutical companies

September 3, 2020
·
5 min read
BioForest

COVID19 UPDATE – Lattice Biologics Announces Cessation of Patient Recruitment

The study was designed to evaluate the efficacy and safety of AmnioBoost in patients with acute respiratory distress syndrome due to COVID19.

September 3, 2020
·
5 min read
Drug Intermediate Market: Fast growing biotechnology and life sciences sectors is expected to drive the growth

Drug intermediates are the drugs used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API.

September 3, 2020
·
5 min read
Sequana Medical announces H1 2020 results and provides business update

Sequana Medical NV, an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, announces its business highlights and financial results for the six-month period ending 30 June 2020 and its outlook for the remainder of the year and into 2021.

September 3, 2020
·
17 min read
FISH Probe Market - Rising Incidence of Various Chronic Diseases Drive the Market Growth

The technique fluorescence in situ hybridization is extensively used by cytogeneticists world over for making fluorescent DNA probes with the aim of detecting a range of chromosomal abnormalities in patients.

September 3, 2020
·
5 min read
Heparin Market: Rising Incidence of Thromboembolic Disorders Drives Demand

The global heparin market is anticipated to attract growth opportunities on the back of the rising count of surgical procedures and increasing treatment of venous thromboembolism including pulmonary embolism and deep vein thrombosis.

September 3, 2020
·
4 min read